|

anti-CD40 antibody 2141-V11 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Memorial Sloan Kettering Cancer Center1

Indications

  • Non-Muscle Invasive Bladder Cancer1
  • Cancer1

Basking Ridge, New Jersey1 trial

Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.